MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 165 filers reported holding MOMENTA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $849,000 | +84.6% | 25,531 | +50.8% | 0.00% | 0.0% |
| Q1 2020 | $460,000 | +189.3% | 16,929 | +38.3% | 0.00% | – |
| Q3 2019 | $159,000 | +4.6% | 12,240 | 0.0% | 0.00% | – |
| Q2 2019 | $152,000 | -20.8% | 12,240 | -7.6% | 0.00% | – |
| Q1 2019 | $192,000 | +9.7% | 13,240 | -16.5% | 0.00% | – |
| Q4 2018 | $175,000 | -65.9% | 15,860 | -18.7% | 0.00% | -100.0% |
| Q3 2018 | $513,000 | +48.3% | 19,516 | +15.4% | 0.00% | 0.0% |
| Q2 2018 | $346,000 | +12.7% | 16,917 | +0.0% | 0.00% | 0.0% |
| Q1 2018 | $307,000 | +37.1% | 16,909 | +5.1% | 0.00% | – |
| Q4 2017 | $224,000 | -24.1% | 16,086 | +0.7% | 0.00% | -100.0% |
| Q3 2017 | $295,000 | +5.4% | 15,971 | -3.6% | 0.00% | 0.0% |
| Q2 2017 | $280,000 | +25.6% | 16,575 | -0.9% | 0.00% | 0.0% |
| Q1 2017 | $223,000 | -7.5% | 16,720 | +4.3% | 0.00% | 0.0% |
| Q4 2016 | $241,000 | +28.2% | 16,026 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $188,000 | – | 16,069 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
| ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
| Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
| SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
| Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
| SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
| Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
| TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |